Pfizer slashes full-year revenue forecast by 13 percent on lower COVID sales Ruchika Sharma15 Oct 2023 6:00 AM GMTNew York: Pfizer has slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to...
Pfizer considers cost cuts as demand for COVID products falls Ruchika Sharma2 Aug 2023 10:00 AM GMTIf COVID vaccinations are very low this year, the company will scale back its investments for the virus, including combination shots, as part of its...
FDA Approves Paxlovid as first Oral Antiviral for Treating COVID-19 in Adults Dr. Kamal Kant Kohli29 May 2023 5:30 AM GMTThe U.S. Food and Drug Administration has approved first Oral Antiviral for Treating COVID-19 in Adults.Paxlovid is the fourth drug-and first oral...
USFDA nod to Pfizer Paxlovid for adult patients at high risk of progression to severe COVID 19 Ruchika Sharma26 May 2023 8:00 AM GMTPAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.
Pfizer beats Q1 profit estimates on demand for newly acquired drugs, COVID products Ruchika Sharma5 May 2023 7:00 AM GMTThe company said it expects significantly lower sales contributions from COVID products in the second quarter from the first quarter.
Paxlovid significantly reduces hospitalization, death risk during Omicron wave Dr. Kamal Kant Kohli13 Feb 2023 2:30 PM GMTUSA: A recent study in CMAJ (Canadian Medical Association Journal) has supported using nirmatrelvir-ritonavir (Paxlovid) for treating patients with...
Demand for affordable Indian generic vaccines skyrocket in China amid COVID surge Ruchika Sharma5 Feb 2023 5:30 AM GMTBeijing: The world observed a brief pause in the Covid-19 insurgence after taking the vaccines, but it did not last for long. China reported a spike...
USFDA removes COVID test requirements for Merck, Pfizer pills Ruchika Sharma2 Feb 2023 6:45 AM GMTThe health regulator said individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID...
Pfizer, Merck rebuff China's push for deeper price cuts on COVID drugs: Bloomberg MD Bureau13 Jan 2023 9:44 AM GMTDelhi: Top US makers of Covid drugs appear to be pushing back on China's efforts to get them to cut their prices, underscoring the challenges the...
COVID surge: Indian generic medicines demand hike in China Ruchika Sharma9 Jan 2023 10:02 AM GMT"On the Chinese e-commerce platforms... At least four generic COVID drugs produced in India - Primovir, Paxista, Molnunat, and Molnatris - have been...
FIRST: Hetero wins WHO Prequalification for generic version of Pfizer COVID drug Paxlovid Ruchika Sharma26 Dec 2022 10:45 AM GMTThe combi pack, launched by Hetero as NIRMACOM, will contain nirmatrelvir 150 mg (2 tablets) and ritonavir 100mg (1 tablet).
Drug price group slashes suggested price of Pfizer COVID drug Paxlovid by 80 percent Ruchika Sharma21 Dec 2022 4:30 AM GMTUS: An influential drug pricing research group has cut its suggested price range for Pfizer Inc's COVID-19 antiviral treatment Paxlovid by more than...
